亿帆医药(002019.SZ)：2’-岩藻糖基乳糖获国家卫健委审查通过

Core Viewpoint - The company Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary, Hangzhou Xinfu Technology Co., Ltd., received an administrative license review conclusion from the National Health Commission of the People's Republic of China for its application regarding 2'-fucosyllactose [1] Group 1 - The National Health Commission approved the application for 2'-fucosyllactose, a significant human milk oligosaccharide [1] - 2'-fucosyllactose is known for its functions in regulating gut microbiota, promoting brain development, and enhancing immunity [1]